Name: Latest research reports of Laurus Labs Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Laurus Labs Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

896.0500 0.45 (0.05%)

NSE Sep 12, 2025 15:31 PM

Near 52W High of ₹922.50

Volume: 1.3M

Laurus Labs Ltd.

28 Jul 2022

896.05

0.05%

Laurus Labs (BUY): Synthesis business saves the day

Buy: Laurus Labs Ltd.

Recommendation

BOB Capital Markets Ltd.

Q1 revenue/EBITDA came in 5%/8% above consensus and grew 20%/ 15% YoY to Rs 15.4bn/Rs 4.5bn

Laurus Labs Ltd. is trading above all available SMAs